Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1612, 2007-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Concerns raised over LNG-IUS use in tamoxifen-treated women
Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. :
Access to resources
Recommend
Phase III Trial of Eprotirome: Discontinued for Safety Concerns
Pharmaceutical Medicine, Vol. 26, Iss. 3, 2012-06 ,pp. :
Concerns remain over safety of aprotinin
Reactions Weekly, Vol. 1, Iss. 1420, 2012-01 ,pp. :
Concerns over the NHS reforms addressed
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 626, 2011-01 ,pp. :
Concerns as hearts `skip a beat' in romidepsin trial
Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. :